SUCLG2 and prostate carcinoma: Activated GLS increased glutaminolysis and upregulated mitochondrial function in prostate cancer cells.[29] In our study, we demonstrated that SUCLG2 knockout led to mitochondrial dysfunction through an increase in the succinylation of mitochondrial proteins and inhibited the function of key metabolic enzymes.